Bodhi Tree Biotechnology Inc (BDTB) stock: key figures, P/E, revenue and dividend
Industrials · United States
Price
0.30 USD
Market cap
7.63 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Bodhi Tree Biotechnology Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 17,000.00 USD |
| Operating income | -147,618.00 USD |
| EBIT | -147,616.00 USD |
| Net income | -149,666.00 USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
More stocks
- MultiSensor AI Holdings, Inc. (MSAI)
- Monroe Federal Bancorp, Inc. (MFBI)
- AMERICAS CARMART INC (CRMT)
- System1, Inc. (SST)
- GT Biopharma, Inc. (GTBP)
- Tempest Therapeutics, Inc. (TPST)
- CFN Enterprises Inc. (CNFN)
- XERIANT, INC. (XERI)
- Bridgeline Digital, Inc. (BLIN)
- Curanex Pharmaceuticals Inc (CURX)
- BTC Digital Ltd. (BTCT)
- Vynleads, Inc. (VYND)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.